National Taiwan University Hospital: Hepatitis B trials
The registry lists 31 Hepatitis B studies with National Taiwan University Hospital as lead sponsor. 3 are open to participants now and 1 have results posted.
Phase 2 1Phase 3 2Phase 4 9No phase 20(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Chronic Hepatitis B Patients With Concurrent MAFLD: Cohort Study and Exercise Intervention.Enrolling by invitationNCT05956379Not applicable
- A Novel Biomarker for Response and Prognosis of HBV-related Hepatocellular CarcinomaNot yet recruitingNCT05752890
- The Immune Responses After Hepatitis B Revaccination Doses in a Young CohortRecruitingNCT04970836Not applicable
- The Hepatitis B Vaccine Booster Response Among the Youth Who Had Completed Neonatal Hepatitis B VaccinesCompletedNCT00792610Not applicableResults posted
- Comparing P1101 to Entecavir in Patients With HBeAg(-) Hepatitis B Under Long-term Nucleos(t)Ide Analogue TherapyStatus unknownNCT05494528Not applicable
- Disease Loads and Status of TreatmentStatus unknownNCT05264272
- Application of 18F-FDOPA PET and Magnetic Resonance Spectroscopy (MRS) With HCV and PDStatus unknownNCT03973502Not applicable
- Hepatitis B Virus Vaccination in HIV-positive Patients and Individuals at High Risk for HIV InfectionStatus unknownNCT03854630Phase 4
- Maternal Screening and Antiviral Therapy in Pregnant Women to Reduce Mother-to-infant Transmission of Hepatitis B VirusStatus unknownNCT03695029Phase 4
- Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide as Maintenance Treatment for HIV/HBV-coinfectionStatus unknownNCT03425994
- Hepatitis B Seroepidemiology Among Young AdultsStatus unknownNCT01973582
- Efficacy Study of Telbivudine in Chronic Hepatitis B PatientsCompletedNCT01958229
- The Follow-up Study of Chronic Hepatitis B Patients With Liver Cirrhosis Receiving Anti-HBV TherapyStatus unknownNCT01957618
- Pegasys Plus Entecavir Versus Entecavir Versus Pegasys for Hepatitis B e Antigen-Negative Chronic Hepatitis BStatus unknownNCT01925820Phase 4
- Using Entecavir to Reduce Hepatitis in Highly Viremic HBV Patients During Anti-tuberculous TreatmentStatus unknownNCT01724723Phase 4
- The Antiviral Therapy in Pregnant Women to Reduce Mother-to-infant Transmission of Hepatitis B Virus-drug TestStatus unknownNCT01312012Phase 4
- Health Promotion and Management for Hepatitis B CarriersStatus unknownNCT01065363Not applicable
- Investigation of Hepatitis B and Hepatitis C in TaiwanCompletedNCT00946010
- Entecavir and Pegasys Sequential Therapy Versus Pegasys for HBeAg Positive Chronic Hepatitis BStatus unknownNCT00921180Phase 4
- Entecavir and Pegasys Sequential Therapy Versus Pegasys for HBeAg Negative Chronic Hepatitis BStatus unknownNCT00917761Phase 4
- Safety Profiles of Liver Biopsy in Hemodialysis Patients With Chronic Viral Hepatitis Pre-treated With VasopressinStatus unknownNCT00635310Not applicable
- Pegasys Plus Entecavir Versus Entecavir Alone for Hepatitis Be Antigen-Positive Chronic Hepatitis BStatus unknownNCT00597259Phase 4
- Long Term Effects of Peginterferon Alfa-2a Plus Ribavirin for Chronic Hepatitis C/B Co-Infection and Chronic Hepatitis CCompletedNCT00361179
- Interferon Alpha 2b Plus Ribavirin for Chronic Hepatitis BCompletedNCT00275938Phase 2/3
- Antibody Response and Immune Memory 15-18 Years After HBV VaccinationStatus unknownNCT00172328Not applicable
- Studies of Immune Responses in Patients With Chronic Hepatitis BCompletedNCT00155155
- Effect of Polymorphisms in the IL-1 Gene Complex on the Development of Chronic Hepatitis and Hepatocellular CarcinomaStatus unknownNCT00155103
- Peginterferon Alfa-2a Plus Ribavirin for Chronic Hepatitis C/Hepatitis B Co-Infection and Chronic Hepatitis CStatus unknownNCT00154869Phase 3
- Identification of Biomarkers Associated With Human Hepatocellular Carcinoma by SELDIStatus unknownNCT00154531
- Immunogenicity of Booster Hepatitis B Vaccines in Children After Liver TransplantationStatus unknownNCT00147459Not applicable
- Pegylated Interferon Alfa-2b Plus Ribavirin in Chronic Hepatitis B and DeltaStatus unknownNCT00117533Phase 4